The Bihormonal iLet Bionic Pancreas Feasibility Study
Status:
Completed
Trial end date:
2019-07-03
Target enrollment:
Participant gender:
Summary
Our objective is to evaluate the function of the bihormonal configuration of the ILet bionic
pancreas delivering dasiglucagon when compared to the insulin-only configuration of the ILet
bionic pancreas in a home-use study in adults with type 1 diabetes.